Direct answer
Health AI Governance, in this evidence assessment, is limited to the following inspected scope. WHO frames health-AI governance through autonomy, well-being and safety, transparency, accountability, inclusion, and sustainability. The principles address multidisciplinary expertise, representative data, independent test sets, appropriate reference standards, human-AI interaction, deployed performance, and user information for ML-enabled medical devices. The answer carries the source boundaries forward and does not infer authority from a neighboring topic.
Evidence assessment
Bind each conclusion to the source and locator that can carry it, keeping contrary or missing evidence visible.
Evidence quality and sufficiency remain claim-specific; one source cannot automatically support every adjacent assertion.
Applied scope: WHO frames health-AI governance through autonomy, well-being and safety, transparency, accountability, inclusion, and sustainability. The principles address multidisciplinary expertise, representative data, independent test sets, appropriate reference standards, human-AI interaction, deployed performance, and user information for ML-enabled medical devices.
Definition and operating context
The canonical concept owner is maha-policy. This route may apply governance; it cannot redefine or inherit the authority of its canonical owner.
This property may publish current-law summaries, policy evidence, Maha proposals labelled as proposals. It must not publish legal advice or proposal presented as enacted law.
Evidence and exact locators
Ethics and governance of artificial intelligence for health — Six consensus principles and governance recommendations. Establishes: WHO frames health-AI governance through autonomy, well-being and safety, transparency, accountability, inclusion, and sustainability.
Good Machine Learning Practice for Medical Device Development: Guiding Principles — Ten guiding principles across the total product lifecycle. Establishes: The principles address multidisciplinary expertise, representative data, independent test sets, appropriate reference standards, human-AI interaction, deployed performance, and user information for ML-enabled medical devices.
What the evidence does not establish
The guidance is broad, non-certifying, and not a substitute for jurisdiction-specific law, clinical evaluation, procurement review, or patient consent. Link and bounded paraphrase only; no WHO text is redistributed.
The scope is medical-device development and does not certify a model, establish clinical benefit, create universal law, or cover every health-AI use.
This route must not claim legal advice.
This route must not claim proposal presented as enacted law.
Related definitions and applications
same-topic-application: https://policy.mahastrategies.com/policy/health-ai-governance/definition
graphEdges: https://policy.mahastrategies.com/policy/tool-governance/definition
same-topic-application: https://policy.mahastrategies.com/policy/health-ai-governance/sources
same-topic-application: https://policy.mahastrategies.com/policy/health-ai-governance/mechanisms
property-home: https://policy.mahastrategies.com/
same-topic-application: https://policy.mahastrategies.com/policy/health-ai-governance/comparison
same-topic-application: https://policy.mahastrategies.com/policy/health-ai-governance/current-law
Questions this page can answer
What does Health AI Governance mean in this bounded context?
Health AI Governance, in this evidence assessment, is limited to the following inspected scope. WHO frames health-AI governance through autonomy, well-being and safety, transparency, accountability, inclusion, and sustainability. The principles address multidisciplinary expertise, representative data, independent test sets, appropriate reference standards, human-AI interaction, deployed performance, and user information for ML-enabled medical devices. The answer carries the source boundaries forward and does not infer authority from a neighboring topic.
Which inspected sources support this evidence answer?
Ethics and governance of artificial intelligence for health (28 June 2021), at Six consensus principles and governance recommendations, supports wHO frames health-AI governance through autonomy, well-being and safety, transparency, accountability, inclusion, and sustainability. Good Machine Learning Practice for Medical Device Development: Guiding Principles (final IMDRF principles noted January 2025; FDA page inspected 2026-09-06), at Ten guiding principles across the total product lifecycle, supports the principles address multidisciplinary expertise, representative data, independent test sets, appropriate reference standards, human-AI interaction, deployed performance, and user information for ML-enabled medical devices.
What does the evidence not establish?
The guidance is broad, non-certifying, and not a substitute for jurisdiction-specific law, clinical evaluation, procurement review, or patient consent. Link and bounded paraphrase only; no WHO text is redistributed. The scope is medical-device development and does not certify a model, establish clinical benefit, create universal law, or cover every health-AI use. Property boundary: This route may apply governance; it cannot redefine or inherit the authority of its canonical owner.
Which definition or canonical owner must be read first?
This page is the local maha-policy definition for its topic. Related applications may depend on it but may not silently redefine it.
What source, policy, implementation, or release change would require revision?
Re-evaluate this page when a cited source, locator, governing instrument, local implementation, or canonical definition changes. Publication also requires a matching exact-revision review and active canonical release.